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Summary 
During immune responses, B lymphocytes may switch from the expression of immunoglobulin 
M (IgM) to the expression of another isotype (e.g.,  IgG, IgE, IgA). In stable hybridomas and 
myelomas expressing a "switched" (S) isotype, DNA deletions between S# and a "downstream" 
S region (S region recombination) have been found. In primary B cells, studies of the molecular 
basis of switching have been limited by the ability to sensitively quantitate the amount of DNA 
deletion; such studies would be of interest because other nondeletional mechanisms (tmns-splicing, 
alternative processing of a long transcript) have been proposed to account for isotype switching 
in certain circumstances. We have applied the digestion-circularization polymerase chain reaction 
(DC-PCR) technique to measure the amount orS region recombination that occurs in the course 
of class switching in primary B lymphocytes. Resting B cells were cultured in lipopolysaccharide 
(LPS) and interleukin 4 (IL-4) to stimulate switching to IgG1. These cells begin to express membrane 
IgG1 at day 2.5 of culture and reach maximum expression by day 4.5. DNA was prepared from 
cultured cells and analyzed for S#-S3q rearrangement by DC-PCR. Chimeric switch regions, 
indicating S/z-S~I recombination, were detected in amounts that, in most cases, correlated with 
surface expression. Furthermore, when cells were sorted on the basis of surface IgG1 expression, 
a mean of at least one S#-$3,1 rearrangement per cell was seen in five out of seven experiments. 
In  general,  the  IgG1 +  cells  obtained at  4.5  and  5.5  d  of culture  had  close  to  2  S/~-S~/1 
rearrangements per cell.  In IgG1-  cells, S#-S~/1 rearrangements were detectable,  but at fre- 
quencies substantially lower that in IgG1 + cells. Thus, these results indicate that DNA deletion 
accompanies class switching in normal B cells stimulated with LPS and IL-4. 
I 
mmunoglobulin  class switching is known to be associated 
with DNA deletion events resulting in the excision of DNA 
between  the  S#  region  and  the  switch  (S) 1 region  of a 
downstream isotype (1). Although it is dear that the majority 
of myelomas and hybridomas that express "switched" iso- 
types have undergone a DNA deletion event of this type, 
there is some doubt as to the general relevance of this process 
in more physiologic switching circumstances (2). Indeed, evi- 
dence has been obtained consistent with alternative splicing 
of very long transcripts or with trans-splicing in certain cir- 
cumstances (3-7). It has also been suggested that one of these 
mechanisms may be an important intermediate in the dde- 
tional switching process  (8). 
DNA deletion has been demonstrated to occur during in 
vitro switching by the isolation of predicted excision circles 
(9-11). Efforts to quantitate DNA deletion during in vitro 
switching, particularly in ceUs stimulated by LPS and IL-4, 
a model in which very vigorous switching to IgG1 and IgE 
1 Abbreviations used in this paler: CSB, cold staining buffer; DC-PCR, 
digestion-circulation  PCR; nAChR, nicotinic  acetylchlorine  receptor B 
subunit  gene;  PI, propidium  iodide;  sIgG1, surface  IgG1, S region,  switch 
region. 
occurs in vitro, have been described (12, 13). However, the 
technique used for these measurements, quantitative Southern 
blotting, lacks the quantitative power to exclude a major role 
for nondeletional mechanisms early in development. Because 
quantitative Southern blotting to measure switch DNA de- 
letion relies on the loss of the germline configuration, it can 
only measure cases where substantial DNA rearrangement 
has occurred and would not be useful where a small amount 
of DNA rearrangement has occurred (e.g., the beginning stages 
of class switching). For that reason,  we have used a newly 
developed quantitative PCR assay, digestion-circularization 
PCK (DC-PCK), to measure class switching DNA rearrange- 
ment (14). DC-PCK has advantages over other methods of 
detecting switch rearrangement (Southern blotting, or di- 
rect PCK) (15, 16) in that (a) a positive signal is produced 
from switched DNA, (b) no signal is produced from germ- 
line DNA, and (c) a single-size product is produced, which 
can then be quantitated. To accomplish this, genomic DNA 
is first digested with restriction enzymes such that the junc- 
tion of the S regions that have been brought together lie on 
a DNA fragment with known EcoRI ends. Then, these frag- 
ments are circularized  by ligation under dilute DNA con- 
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amplification is performed across the ligated EcoRI ends.  A 
uniform-sized fragment is produced regardless of the struc- 
ture of the S region junction. 
For switching to IgG1, quantitation relies on the measure- 
ment of the number of copies of S1*-S'71 and of a control 
gene,  the  nicotinic  acetylcholine receptor/3  subunit  gene 
(nAChR, nAChRe). Because nAChR DC-PCR produces a 
signal from unrearranged DNA, it serves as a control for DNA 
preparation, restriction digestion, and ligation. The amount 
of S/z-ST1  rearrangement  is determined  from the ratio of 
S/~-S'y1  and nAChR copies. The measurement  of S/z-S~/1 
and  nAChR  copies  relies  on  the  introduction  of known 
amounts of competitive plasmid templates p4AP and p2A0, 
respectively (14,  17).  Normal B cells induced to switch to 
IgG1 by LPS and IL-4 were analyzed for surface IgG1 ex- 
pression and DNA rearrangement (S/z-S'y1) at several different 
time points. At all time points analyzed, sttffldent DNA rear- 
rangement had occurred to account for the number of cells 
expressing surface IgG1.  Furthermore,  analysis  of S/~-$3'1 
DNA rearrangement  from cells sorted on the basis of IgG1 
expression showed that  most IgG1 + cells  had at least one 
chromosome rearranged  and that a small percentage of IgG1- 
ceUs had at least one chromosome rearranged. Thus, our ex- 
periments support the notion that DNA rearrangement  occurs 
with  expression of the new isotype in normal  B  ceils. 
Materials and Methods 
Cell Culture.  Resting B cells were prepared from spleens of 8-12- 
wk-old female C57BL/6 mice obtained from the Frederick Cancer 
Research  and  Development  Center,  National  Cancer  Institute 
(Frederick,  MD) as described previously (18). Briefly, dispersed 
splenocytes were depleted of T cells by treatment  with anti-T cell 
antibodies (monoclonal rat anti-mouse anti-Thy 1.2 (HO-13-4-9) 
(19), anti-CD5  (53-7.313) (20), and anti-CD8  (53.6.7)  (20), or 
(3.155) (21) followed  by monoclonal mouse anti-rat antibody (MAR 
18.5) (22) plus guinea pig complement  (GIBCO BILL, Gaithers- 
burg, MD). From the resulting B cell-enriched fraction, small dense 
resting  calls (66-70%  fraction)  were isolated by centrifugation 
through a discontinuous  Percoll (Pharmacia LKB Biotechnology, 
Inc., Piscataway, NJ) gradient. These cells were cultured in RPMI 
1640 (Biofluids, Rockville, ME)) supplemented with 5% fetal bo- 
vine serum  (Biofluids), 2 mM L-glutamine (Biofluids), 50 /*M 
2-mercaptoethanol (Sigma Chemical Co., St. Louis, MO), 1 U/m1 
penidllin  G potassium (Biofluids), 1/~g/ml streptomycin sulfate 
(Biofluids), plus 20/~g/ml LPS (LPS W Esckerichia coli Ol11:B4; 
Difco Laboratories, Detroit,  MI) with or without recombinant 
mouse II:4 (10,000 U/m1, ,,~0.46 ruM) (23) at 37~  and 6% CO2. 
Celt Su~ce Marker Analysis and Sorting.  Cell surface IgG1 and 
IgM was measured by standard flow cytometry techniques (24). 
Briefly, B cells were washed three times in cold staining buffer (CSB) 
(3% fetal bovine serum in HBSS without phenol red [Biofluids]) 
and resuspended at a final concentration  of 5-10  x  10  ~ cells/ml 
of CSB. One hundred/~1 of cell suspension was stained with goat 
anti-mouse anti-IgG1 coupled to FITC and/or anti-IgM coupled 
to R-PE (Southern Biotechnology Associates, Inc., Birmingham, 
AL) at a final concentration of 10/~g/ml for 30 rain at 4~  Stained 
cells were washed three times in CSB, and resuspended in 500/~1 
CSB plus 10/~150/~g/ml  propidium iodide (PI) (Sigma Chemical 
Co.) (in 0.1%  sodium citrate  [Mallinckrodt,  Inc., Paris, KY] in 
PBS, pH 7.4) (Biofluids) before cytometric analysis by FACScan  | 
or cell sorting by FACStar#  ~  (both from Becton Dickinson  Im- 
munocytometry Systems, San Jose, CA) or Epics 753 (Coulter Elec- 
tronics, Inc., Hialeah, FL). Dead cells and clusters were removed 
from analysis or sort by gates on PI staining and on size using for- 
ward and side scatter. 
DNA.  DNA from B cells was prepared by standard methods 
(25). Briefly, the cells were lysed in 0.5% SDS (National Institutes 
of Health [NIH] Media Unit, Bethesda, MD), 10 mM Tris-HC1, 
pH 7.5, (NIH Media Unit),  100 mM NaC1 (Mallinckrodt), 50 mM 
EDTA (NIH Media Unit),  and 0.2 mg/ml proteinase K (Sigma 
Chemical Co.) at 37~  overnight.  The lysate was extracted with 
an equal volume of phenol (Fluka Chemie AG, Buchs, Switzer- 
land) and Sevag (chloroform:isoamyl alcohol [both from Mallin- 
ckrodt]  [24:1]) and  dialyzed  in  Spectrapor2  membrane  tubing 
(6.4-mm cylindrical diameter, 12,000-14,000 m.w. cutoff) (Spec- 
trum Medical Industries,  Inc., Los Angeles, CA) against 10 mM 
Tris-HC1, pH 7.5, 1 mM EDTA. The sample was treated with 1 
/z110 mg/ml RNase (Ribonuclease A, Type  X-A; Sigma Chemical 
Co.) at 37~  for several hours and then extracted and dialyzed as 
before. DNA concentration  was determined by UV absorption at 
260 and 280 nm. 
Precise DNA concentration  of competitive plasmid templates, 
p4AP and p2AO (14), was determined  by fluorometry  (Hoefer 
Scientific Instruments,  San Francisco, CA). 
DNA oligonucleotide primers were prepared on a DNA syn- 
thesizer (Applied Biosystems, Inc., Foster City, CA) and purified 
through  NAP-5 columns (Pharmacia LKB) under conditions sug- 
gested by the manufacturer. Primer concentration was determined 
by UV absorption  at 260 and 280 nm.  Primers for control DC- 
PCR  of the  nicotinic  acetylcholine  receptor  B  subunit  gene 
(nAChP,) (5' GGC CGG TCG ACA GGC GCG CAC TGA CAC 
CAC TAA G and 5' GCG CCA TCG ATG GAC TGC TGT GGG 
TTT CAC CCA G) generate a 490-bp PCR product from plasmid 
p2AO or a 753-bp PCR product from digested and circularized 
genomic DNA template (14). The 5' # primer (5' GGC CGG TCG 
ACG GAG ACC AAT AAT CAG AGG GAA G) and 3' "yl primer 
(5' GCG CCA TCG ATG GAG AGC AGG GTC TCC TGG GTA 
GG) generate a 265-bp PCR product from p4AP or a 219-bp PCR 
product from digested and circularized genomic DNA template (14). 
DC-PCR.  DC-PCR was performed as described previously (14) 
and is described here in detail. 
Genomic DNA (2/~g) was digested in  100/~1 with 50 U of 
restriction endonuclease  EcoRI (New England Biolabs, Inc., Beverly, 
MA) in buffer supplied by the manufacturer  at 37~  overnight. 
EcoRI was subsequently inactivated by incubation at 70~  for 20 
rain. 
Digested DNA samples were diluted to 1.8/~g/ml  in standard 
ligation buffer (50 mM Tris-HC1, pH 7.4, 10 mM MgC12, 10 mM 
dithiothreitol,  I mM spermidine, 100/~g/ml BSA, 0.7 mM ATP) 
(25). For ligation, 2 U ofT4 DNA ligase (Bethesda Research  Labora- 
tories, Gaithersburg, MD) or 400 U of T4 DNA ligase (New En- 
gland Biolabs) was added to a final volume of 100/~1 and incubated 
at 16~  overnight.  These conditions allow for greater than 90% 
circularization of digested DNA fragments of size 15 kb or less 
(26). The S/z-ST1 EcoRI fragment is estimated to be up to 15 kb 
(27). 
To monitor the efficiency  of digestion and circularization of each 
sample, PCK was performed on ligated DNA with nAChR primers. 
5 ng of ligated DNA was amplified in 20/~1 nAChR PCR buffer 
(1.5 mM MgCh, 10 mM Tris-HC1, pH 8.0, 50 mM KC1, 0.5/~M 
nAChR primers, 200/~M of each dNTP) (Pharmacia), p2AO (222 
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Corp., Indianapolis,  IN) or recombinant  Taq DNA polymerase  (Am- 
pliTaq; The Perkin-Elmer Corp.,  Norwalk,  CT)  overlaid with 
mineral oil (Sigma Chemical Co.). Amplification was always  per- 
formed in a DNA Thermal Cycler (Perkin-Elmer Corp.) under the 
following conditions: 94~  for 6 min, 5 cycles  at 94~  for 1 min, 
65~  for 1 min, and 72~  for 2 min; 30 cycles at 94~  for 1 min, 
68~  for 1 min, and 72~  for 2 min; 72~  for 7 min. 
PCR products were analyzed by standard PAGE (8%)  (25). 
Briefly,  10/zl of  sample plus 1/~1  of  loading  dye (0.25  % bromophenol 
blue, 0.25% xylene cyanol, 30% glycerol  in HzO) was electropho- 
resed through 8% polyacrylamide (Bio-Rad Laboratories, Rich- 
mond, CA, or National Diagnostics, Atlanta, GA) gels in lx TBE 
(89 mM Tris-borate, 89 mM boric acid, 2 mM EDTA) buffer. After 
bromophenol blue was electrophoresed to the bottom of the gel, 
the gel was stained  in a 0.5/~g/ml ethidium bromide solution (Sigma 
Chemical Co.), visualized  by a 300-nm UV transilluminator (UVP, 
San Gabriel, CA),  and recorded by photography with Type 57 
4  x  5 Instant  Sheet Film (Polaroid Corp.,  Cambridge, MA). 
Subsequently, each sample was tested by S/~-$3'1 DC-PCR 
amplification. 5 ng of ligated DNA was amplified as before in 
S/~-S~/1 PCR buffer (2.0 mM MgCh, 10 mM Tris-HC1, pH 9.0, 
50 mM KC1, 0.5/zM 5'/z primer, 0.5/zM 3' 34 primer, 200/zM 
of  each dNTP) (Pharmacia), p4AP (222 copies) and 1.5 U Taq DNA 
polymerase. 
Quantitative  DC-PCR.  Initial  quantitation  of nAChR and 
S/z-S3"1 copy number was done by a competitive substrate method 
(14, 17). To quantitate  nAChR copy number,  the competitive 
plasmid template p2AO was titrated (6,000, 2,000, 667, 222, 74, 
25, 8 copies) into a constant amount of digested and circularized 
genomic  template (5 ng).  The resulting  DNA mixtures  were 
amplified in 20/~1 nAChR PCR buffer, 1.5 U Taq DNA poly- 
merase, and 0.1/zl [ot-32P]-dCTP (3,000 Ci/mmol) (Amersham 
Corporation, Arlington Heights, IL). To quantitate S/z-$34 copy 
number, the competitive plasmid template p4AP was titrated as 
above into a constant amount of genomic template. The resuhing 
DNA mixtures were amplified  in 20 #1 S/~-S3q PCR buffer, 1.5 U 
Taq DNA polymerase, and 0.1/~1 o~-[3zP]-dCTP (3,000 Ci/mmol). 
The competitive plasmid and genomic templates generate different 
sized PCR products from the same primer set. After resolving  PCR 
products on 8% PAGE, the gels were dried for 1 h at 80~  on 
a  gel  dryer  (Hoefer  or  Bio-Rad) and  autoradiographed  with 
X-OMAT  TM AR diagnostic film (Eastman Kodak Co., Rochester, 
NY). 
Data Analysis.  The amount of PCR products generated from 
plasmid and genomic  templates was  measured by one of two 
methods: (a) dried gels containing radioactive PCR product were 
counted  on a radioanalytic imaging  system (Mark II;  AMBIS 
Systems, San Diego, CA, courtesy of  Dr. Ida Owens, National In- 
stitute of  Child Health and Human Development) or (b) autoradio- 
graphs were scanned on a computing densitometer (Molecular  Dy- 
namics, Inc., Sunnyvale,  CA). Bands on the gel or autoradiograph 
corresponding to plasmid  and genomic template PCK product were 
measured as radioactive  counts or arbitrary volumetric units. Back- 
ground counts or volumes were subtracted. To measure the rela- 
tive molar amounts ofplasmid and genomic template PCK product, 
the measured counts or volumes were adjusted for the amount of 
radioactive cytosine  incorporated  into each  product. In nAChR DC- 
PCR, the measurement of the genomic template PCR product 
was multiplied by 238/342,  because the p2AO generated PCR 
product contains 238 cytosines and the genomic template gener- 
ated PCR product contains 342 cytosines.  Similarly,  in S/z-S3~I DC- 
PCK, the genomic template generated PCR product measurement 
was multiplied by 108/89. 
The amount of  nAChR geue copies  in the sample is determined 
to be the number of copies of p2AO that generate an amount of 
PCR product equal to the amount generated by the genomic tem- 
plate. The number of S#-$34 copies is similarly determined rela- 
tive to p4AP. The equivalence point where PCR product gener- 
ated by plasmid and genomic templates are equal was determined 
graphically. The log(genomic template product/plasmid temphte 
product) was calculated and plotted versus the log(plasmid copy 
number) with the aid of Microsoft Excel (Microsoft Corporation, 
Redmond, WA) and Cricket Graph (Cricket Software, Malvern, 
PA) Macintosh programs. A best fit line was used to determine 
the number  of plasmid copies at the equivalence point  where 
log(genomic template product/plasmid template product)  =  0. 
After determining  nAChR and S/z-S3,1 copy number  for a 
sample, a value  for the amount of  S/z-S71 rearrangement  per diploid 
genome in a sample  is given by S/z-S'),I copies/(nAChK copies/2). 
This number is divided by 1.89, a normalization factor determined 
from a cell line with known nAChR and S#-$3,1 copy numbers 
(14), and then expressed as a percentage to yield an accurate mea- 
sure of S/z-$34 rearrangement. In theory, this measurement can 
vary from 0 to 200%, the latter indicating two S#-S3rl rearrange- 
ments per diploid genome. 
More accurate  quantitation of  nAChR and S#-$3,1 copy number 
in most samples was done by a serial dilution method to ensure 
that the PCR was performed in the exponential range of the reac- 
tion (14, 28). Briefly, each sample, a mixture  containing 5 ng 
digested-circularized genomic DNA plus an amount of plasmid 
template such that the amount of plasmid was close to the equiva- 
lence point, was serially  diluted 1:2 four or five times, nAChR and 
S#-$3,1 DC-PCK amplification was performed on each point of 
the dilution series in the same solutions and same conditions as 
described for initial quantitation. PCR products were separated  by 
gel electrophoresis and measured as described above. Calculations 
to determine the number of nAChR and S/~-S'),I copy numbers 
are described in the Results in conjunction with Fig. 3. 
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Kinetics of the appearance  of IgG1 bearing B cells. B cells 
were cultured and LPS and IL-4  for the days  indicated  and IgG1 surface 
expression was measured by flow  cytometry.  The results of three experi- 
ments are shown.  B cells  cultured  in LPS alone  served  as the negative  control. 
1383  Chu et al. Figure  2.  Representative example of quantitation of S#-$3'1 and nAChR copy number by competitive plasmid titration. (A) The expected size 
PCK products and starting templates are shown for nAChK primers and for 5'# and 3'3'1 primers. Arrows representing primer homologous sequences 
point in direction of polymerization (5' to 3'). Thick lines indicate DNA template, nAChK and S#-$3'1 label the genomic template for nAChK and 
5'# and 3'3'1 primers, respectively.  Shaded line and connecting vertical dotted lines indicate DNA deleted to make the competitive substrate, p2AO. 
Open box and connecting vertical dotted lines indicate DNA inserted to make the competitive substrate, p4AP. (B) Titration of p2AO into constant 
amount of digested-circularized  genomic template and subsequent PCR on the mixture with nAChK primers is shown. Inset shows autoradiograph 
of PCK products after separation on 8% PAGE. The number of p2AO copies and the presence of 5 ng genomic template (+) in starting mixture 
is labeled above each lane. Graph illustrates the gel data after counting, nAChK and p2AO label PCK product from genomic and phsmid template, 
respectively. (C) Same as B except to measure S#-$3'1 copies, titration uses p4AP instead of p2AO and PCR uses 5'# and 3'3'1 primers instead of 
nAChK primers. (D) To calculate nAChK and S#-$3"1 copy number, the results from B and C are graphed as shown. Copy number is determined 
from best fit lines where PCK product from plasmid and genomic templates is equal (log[p2AO/nAChK] =  0 and log[p4AP/S#-S3,1] =  0). This 
sample (IgG1  + B cells obtained by sorting after 2.5 d culture with LPS  +  I1:4) has 205 nAChK copies and 109 S#-$3'1 copies. 
Results 
Kinetics of lgG1 Surface Expression in B Cells Treated with 
LPS and IL-4.  Using flow cytometry, the kinetics of IgG1 
surface expression on B  cells treated with  LPS and  IL-4 is 
shown  in  Fig.  1,  which  represents data drawn  from three 
separate experiments. No surface IgG1 is detected before 2.5 d 
of culture. The fraction of cells expressing surface IgG1 reaches 
maximum at about day 4.5. If IL-4 is omitted from the cul- 
ture,  no  surface  IgG1  positive  cells  are detected  (data  not 
shown). Based on this, we concentrated on examining DNA 
from cell populations cultured for 2.5-5.5 d for quantitation 
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of S#-S'y1 DNA rearrangement. We have previously reported 
that  no  rearrangement  is  detectable before 2.5  d  (14). 
Quantitative DC-PCR Measurement of Slt-S~/1 Rearrange- 
ments.  To measure DNA deletion occurring during S#-$3'1 
rearrangement, we utilized the technique of quantitative DC- 
PCK  (14). 
Initial quantitation was performed by titration of plasmid 
into a constant amount of genomic template and performing 
PCK  on the mixtures.  A  representative example is  shown 
in Fig.  2. The amount of nAChR in the sample is equal to 
the amount of p2AO, the competitive plasmid template, that Figure  3.  Representative  example of further quantitation of S#-S"/1  and nAChR copy number by serial dilution. Genomic template comes from 
B cells cultured with LPS  +  ID4 for 2.5 d and sorted for IgG1 + as in Hg. 2.  (A) Autoradiograph of PCR products from a reaction using nAChR 
primers on a serial doubling dilution of a mixture of digested-circularized  genomic template (5 ng) and 222 copies of p2AO and subsequently resolved 
by 8% PAGE. Dilution is shown above each lane. (B) Same as A  with the exception that starting DNA mixture contained 222 copies p4AP instead 
of p2AO and PCR used 5'/* and 3'~,1 primers instead of nAChR primers.  (C) nAChR copy number is calculated  from data in A  by determining 
parallel best fit lines for both nAChR genomic template and p2AO template PCR products with respect to log (dilution). Points where PCR amplification 
reached a plateau (Dilution I) were discarded from consideration. The difference in log (dilution) between both lines (p2AO -  nAChR) was multiplied 
by the number of p2AO copies in the starting mixture (222) to determine the number of nAChR copies in the starting mixture. 136 nAChR copies 
was found in this case. (D) St~-Syl copy number was determined from the data in B in a similar manner as in C. Parallel best fit lines for both S#-Syl 
genomic and p4AP template versus dilution were calculated. The equations were solved as in C with the knowledge that the starting mixture contained 
222 copies  of p4AP,  resulting in a calculation of 121 S/~-Syl copies. 
gives an equivalent amount of PCR product. This can be 
visualized in Fig.  2 B as the point where the nAChR and 
p2AO lines intersect. The amount of S#-S'),I is determined 
similarly with reference to the amount of p4AP as shown 
in Fig. 2 C. From these two graphs, the number of nAChR 
and S/~-Sq,1 copies is calculated as shown in Fig. 2 D  to be 
205 and 109 copies, respectively. The amount of S#-$3,1 rear- 
rangement is calculated  as described in the Materials  and 
Methods to be 109/[(205/2)  x  1.89]  x  100 or 56.2%. 
More precise quantitation was performed by serial dilu- 
tion of a mixture of plasmid and genomic template near the 
equivalence point determined from titration experiments as 
shown in Hg. 3. PCR amplification was performed on serial 
dilutions of a mixture of genomic template and 222 copies 
ofplasmid template as shown in Fig. 3, A and B. A negative 
control containing plasmid template and digested, but un- 
ligated genomic DNA resulted in no detectable genomic PCR 
product indicating that there is no contaminating carryover 
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of previously amplified product in the PCR reaction mix (data 
not shown). The number of nAChR copies was determined 
by plotting the log(genomic template product) and log(p2AO 
product) versus the log(dilution) (Fig. 3 C). A best fit line 
was determined for both genomic and p2AO products. In 
theory, these lines should be parallel with a slope of one. In 
a set of 131 experiments, the observed slopes were 1.14  _+ 
0.39. For each experiment, parallel best fit lines were deter- 
mined by calculating the average slope, statistically weighted 
for the number of points in each data set, and the centroid 
(average values of x and y) for data derived separately from 
genomic and plasmid templates. The nAChR copy number 
is determined from these two parallel lines by multiplying 
the x difference in log(dilution) between the p2AO and the 
genomic lines times the number of p2AO copies. The number 
of S#-S3,1  copies is determined similarly by plotting log- 
(genomic template product) and log(p4AP product) versus 
the log(dilution) (Fig.  3 D).  The amount of S~-$3,1  rear- Table  1.  SIr  Rearrangements in  Unsorted B  Cells 
slgG 1 +  S/z-S'y1/ 
Treatment  Time  ceUsS  nAChRII  Experiment  Method 
LPS 
LPS  +  IL-4 
d  %  % 
2.5  0.5  <1.8  E.12-12  Titration 
0.2  (0.8  E.17-1  Titration 
4.5  2.1  <2.7  E.12-12  Titration 
3.6  <1.4  E.17-1  Titration 
2.5  4.9  3.8  E.12-12  Dilution 
4.6  2.5  +  0.2*  E.12-14  Dilution 
8.8  16  E.17-1  Dilution 
3.5  33  65  E. 17-4  Dilution 
30  42  E. 17-5  Titration 
4.5  29  76  _+ 24.1*  E.12-12  Dilution 
51  84  _+ 20.5*  E.12-18  Dilution 
35  103  +_  16.4"  E.17-1  Dilution 
5.5  36  43  E. 12-9  Titration 
* Average of 2. 
* Average of 4. 
S Surface IgG1 + B cells as determined  by FACS  |  analysis. 
II A measure  of S/x-S"/1 rearrangement  determined by (S/x-S"/I copies)/[(nAChR copies/2)  x  1.89]  x  100. 
rangement per diploid genome in a sample is calculated from 
nAChR and S/~-$3~1 copy numbers as above.  The nAChR 
and S/x-S3'1 copy numbers are calculated from this data to 
be 136 and  121 copies, respectively, as shown in Fig. 3,  C 
and D. Thus, the amount of S/~-S~/1 rearrangement is calcu- 
lated to be 121/[(136/2)  x  1.89] or 94.1%. In this example, 
the estimate of the frequency of S#-S'y1 rearrangement  by 
dilution is 1.6-fold greater than that estimated by titration, 
illustrating the importance of performing serial dilution quan- 
titation.  However, the values from the two procedures are 
usually substantially closer, unless there is a significant pla- 
teau in the PCR amplification  during  the initial  quantita- 
tion as seen in Figs. 2 C and 3, A and C. Thus, for all experi- 
ments  we  used  both  titration  and  dilution  quantitation 
wherever possible. 
Switch Rearrangement Can Account  for Surface Expression in 
B Cells.  Mouse B cells were cultured in LPS with or without 
IL-4 for 2.5-5.5  d and assayed for IgG1 surface expression 
by FACS  |  and S/z-S3,1 rearrangement  by quantitative DC- 
PCR as shown in Table 1. The day 2.5 time point was chosen 
because that is when calls are just beginning to become IgG1 
surface positive (Fig.  1) and because no S/z-Syl rearrange- 
ment is observed before this time (14). The day 4.5 time point 
was chosen because that is when the maximum number of 
B cells are surface IgG1 positive (Fig. 1). B cells cultured with 
LPS alone express no detectable surface IgG1 at 2.5 d, as shown 
for two experiments in Table 1. A low percent of surface posi- 
tive ceUs (2.1 and 3.6%) in two experiments at 4.5 d is dose 
to the detection limit of FACS  |  analysis with our reagents. 
B ceils cultured in LPS only fail to produce detectable S#-$3,1 
rearrangement at 2.5 or 4.5 d; the limits of sensitivity of the 
assays ranged  from 0.8 to 2.7%  (Table  1). 
The percentage of B cells cultured in LPS and IL-4 that 
become surface IgG1 + varies from a minimum  of 4.6% on 
day 2.5 to a maximum of 51% on day 4.5 as shown in Table 
I for seven experiments at four time points. In most experi- 
ments, S#-S'y1 rearrangements as measured by DC-PCR oc- 
curred at percentages above those observed for IgG1 + sur- 
face expression except for two cases at day 2.5. In these cases, 
we obtained values of 2.5% S/z-S'),I rearrangement with 4.6% 
surface IgG1 + and 3.8%  rearrangement  and 4.9%  surface 
IgG1 +.  The discrepancies could reflect measurement  inac- 
curacy,  particularly since estimates of both surface IgG1 ex- 
pression and S/z-S3,1 rearrangement  are near their limit of 
sensitivity. Alternatively, these cells may have been "caught" 
at a slightly earlier point in the differentiation process when 
DNA rearrangement  may not yet have occurred in some of 
the cells  that  already express surface IgG1. 
Because in most cases, the percent S/z-S3'1 rearrangement 
exceeds the percentage  of IgG1 + cells (see Table  1),  there 
must be either more than one chromosome rearranged  in some 
of the IgG1 + cells or some of the IgG1-  ceils must contain 
an S/z-S',/1  rearrangement.  To test this,  we sorted cells on 
the basis of IgG1 surface expression as shown in Fig. 4. After 
sorting,  purity was determined by reanalysis of IgG1 + sur- 
face expression on the sorted cell populations. DNA was pre- 
pared from these cells and quantitative  DC-PCR was per- 
formed to determine the amount of S/~-$3,1 rearrangement. 








I  I  I  i'  IgG1 
'  '  "  46% 
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97% 
I  I  IgG1 
Figure 4.  l~presentative  ex- 
ample of sorting B cells on the 
basis of IgG1 expression. B cells 
cultured with LPS  +/-  I1,4 for 
2.5  d  were  stained with  anti- 
IgM-PE  and  anti-IgG1-FITC. 
Stained cells were analyzed and 
sorted  on  a  FACStarp  1us. Flow 
cytometric two-dimensional con- 
tour plots are shown with fluores- 
cence intensity of anti-IgG1-FITC 
staining on the x axis and of anti- 
IgM-PE staining on the y  axis. 
The upper two plots show the 
pre-sort analysis of cells cultured 
in LPS only or LPS +  IL-4 in the 
left and right, respectively. The 
two boxes in the upper right plot 
indicate  the  sorting  gates  for 
IgG1- and IgG1 + cells in the left 
and right, respectively.  4.6% is the 
percentage of IgG1 + cells in the 
starting population.  The  lower 
two plots show the post-sort anal- 
ysis of IgG1-  and  IgG1 +  cells 
from the LPS  +  Ib4 culture in 
the left and right,  respectively. 
The boxes in the lower plots are 
the sorting gates. The percentages 
shown in the lower plots are the 
percentage of cells in the lgG1 - 
and  IgG1 +  sorted  populations 
that are within the IgG1-  and 
IgG1 +  sort  gates,  respectively 
(purity of sort). In this example, 
3.2  x  106 and 9.7  x  104 IgG1- 
and IgG1 + cells were collected, 
respectively. Typically, >105 cens 
were  collected  to  insure  that 
sufficient DNA could be prepared 
for the DC-PCR assay. 
The  results  of analysis  of IgG1 +  ceils in  seven  cases  at 
three time points are summarized in Table 2.  The purity of 
these sorted ceils (percent slgG1 +) ranged from 72 to 97%. 
The measured S/~-$3,1 rearrangement in these cells is greater 
than  the  percent  slgG1 §  in five of these  cases.  Four  mea- 
surements  are greater than  100%,  implying that some cells 
have two S#-$3'1 rearrangements.  Percentages >200 are the- 
oretically impossible and most probably reflect error in the 
Table  2.  S/~-8~1  Rearrangements  in Sorted B  Cells from LP$  +  IL-4  Cultures: slgGl + Cells 
Time  sIgG1 +  cells*  S#-S3,1/nAChRS  Experiment  Method 
d  %  % 
2.5  97  86  E. 12-14  Dilution 
81  94  E. 17-1  Dilution 
72  61  E. 17-2  Dilution 
4.5  87  249  E. 12-12  Dilution 
81  139  _+  80.4*  E.12-18  Dilution 
97  241  _+  12.6"  E.17-1  Dilution 
5.5  95  147  E. 12-9  Titration 
* Average of 2. 
* Surface IgGl+ B cells as determined by FACS  |  analysis. 
S A  measure of S#-$3,1 rearrangement determined by (S/z-S3,1 copies)/[(nAChR copies/2)  x  1.89]  x  100. 
1387  Chu et al. Table  3.  S/z-ST1 Rearrangements in Sorted B Cells  from LPS + 
IL-4 Cultures: slgG1-  Cells 
Time  slgG1 + calls* S#-S3d/nAChR*  Experiment  Method 
d  %  % 
2.5  2.7  4.4  E.12-12  Dilution 
1.0  4.0  E.12-14  Dilution 
3.5  1.3  38  E.17-4  Dilution 
0.1  16  E. 17-5  Titration 
4.5  0.0  12  E.12-12  Dilution 
0.3  6.9  E. 17-1  Dilution 
5.5  0.0  6.6  E.12-9  Titration 
* Surface IgG1  + B cells as determined by FACS  |  analysis. 
t A measure of S/z-S3,1 rearrangement determined by (S/~-S'y1 cop- 
ies)/[nAChR copies/2) x  1.89] x 100. 
DC-PCR measurements. However, in such cases it seems very 
likely that virtually all the surface IgG1 + cells have under- 
gone  two  S#-S'y1  rearrangements.  Two out  of the  seven 
S/~-S'y1 rearrangement  measurements are less than the ob- 
served percent  slgGl+:  61 versus 72% and 86 versus 97% 
in the day 2.5 samples.  These discrepancies may reflect mea- 
surement  inaccuracy or a subpopulation  of surface IgG1 + 
cells  that  do not contain  S#-$3'1  rearrangements. 
The  analysis  of surface IgG1-  cells from  seven  cases  at 
four time points is summarized  in  Table  3.  The purity of 
the sorted populations was quite good, with surface IgG1 § 
cells ranging  for 0-2.7%. In all seven measurements,  some 
S/x-S3'I rearrangement  is detectable and always exceeds the 
level that could be accounted for by contaminating  IgG1 + 
cells. Interestingly,  the two highest values for S#-S'y1 rear- 
rangement in surface IgG1-  cells are observed at day 3.5 and 
are substantially greater than the values seen on days 4.5 or 
5.5. The S#-$3'1 rearrangement  found in IgG1-  cells could 
be due to rearrangement  on the unexpressed chromosome 
or to rearrangement  on the expressed chromosome in cells 
that  have not yet expressed surface IgG1. 
Discussion 
To determine if deletional mechanisms could quantitatively 
account for class switching in normal lymphocytes, we ana- 
lyzed switching to IgG1 in B calls cultured in LPS and IL-4 
by flow cytometry and by the newly developed DC-PCR assay. 
This allows us to measure  surface IgG1  and S#-Sqrl  rear- 
rangement,  respectively. 
DC-PCR is well suited to measure switch events, particu- 
larly those that occur in a small fraction of the cells under 
study, since the rearrangement is detected by the appearance 
of unique products (i.e.,  the DNA fragment containing the 
chimeric S#-$3,1 region and the ligation circularized DNA 
and PCR products derived from it). By contrast, other tech- 
niques that attempt quantitation of DNA deletional switch 
events usually rely on the loss of the germline configuration 
of C'y1, which is accurate only when  the fraction of cells 
undergoing the switch event is substantial,  since it depends 
upon subtracting the frequency of"unswitched" chromosomes 
in the experimental condition from that in the control con- 
dition. Nonetheless, it should be noted that Radbruch et al. 
and Kepron et al. were able to show that among B cells de- 
rived from cultures stimulated with LPS and IL-4, (13) a sub- 
stantial degree of loss of unrearranged C3'1 occurred in sur- 
face IgM-negative cells (12) and surface IgGl-positive cells, 
implying  that  DNA  deletion  accounted for much  of the 
switching  events in these cells. 
The results we obtained with DC-PCR are also consis- 
tent with the deletional model of class switching.  Indeed, 
DNA deletion in unsorted B cells stimulated with LPS and 
IL-4 was sufficient in seven of nine cases to account for sur- 
face IgG1 expression.  In the remaining  two cases,  a small 
measurement  inaccuracy could account  for  the  difference. 
Among  IgG1 +  cells  obtained  by  cell  sorting,  suf~cient 
DNA deletion to account for IgG1 surface expression was 
observed in five out of seven cases. Again, measurement in- 
accuracy could account for the small differences (86 versus 
97% and 61 versus 72%) in the remaining two cases. These 
results thus indicate that at all times throughout the culture, 
even at the earliest time that slgG1 + cells could be detected 
(2.5 d), sufficient switch recombination exists to explain the 
expression of the switched isotype. 
In IgG1- cells purified from cultures stimulated with LPS 
plus  IL-4,  DNA  deletion  was detected above the level  of 
IgG1 + cell contamination  in  all cases.  This is particularly 
striking since B cells cultured with LPS alone failed to dis- 
play detectable S#-$3,1 rearrangement,  under conditions in 
which such events could have been detected in from 0.8 to 
2.7% of the cells, depending on the individual experiment. 
The observation that slgG1- cell populations invariably ex- 
press evidence of some S/~-$3,1 rearrangement  is consistent 
either with rearrangement  occurring before surface expres- 
sion of IgG1 (i.e., the cells have been "caught" after the DNA 
rearrangement  event but prior to expression of cell surface 
IgG1) or with S/~-$3'1  rearrangement  occurring  to a sub- 
stantial  degree on  the non-expressed chromosome in cells 
whose expressed chromosome has not undergone such rear- 
rangement.  Although we can not unequivocally distinguish 
between these two possibilities, the apparent accumulation, 
with time,  of switch events in IgG1 + cells,  as reflected by 
the increase in the frequency of chromosomes that have un- 
dergone rearrangement  in  IgG1 + cells from '~1  (i.e.,  per- 
cent of switched chromosomes divided by percent of IgG1 + 
cells)  at day 2.5 to ,,ol.8 at days 4.5 and 5.5 indicates  that 
the majority of the unexpressed chromosomes in IgG1 + cells 
will eventually undergo switch events to S'y1. This is consis- 
tent with results from the analysis  of loss of germline C3d 
in LPS plus IL-4 stimulated cells (12, 13) and from the work 
of others who demonstrated that among hybridomas, switch 
recombination  to the non-expressed C  region  of the same 
isotype as that on the productively rearranged chromosome 
occurred with  a considerable frequency (29-31). 
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mosomes was greater in IgG1- cells at day 3.5 (38 and 16% 
in two experiments) than in IgG1- cells at days 4.5 and 5.5 
(12,  7,  and 7%)  suggests that IgG1-  cells in which dele- 
tional  switch events occurred often became IgG1 +.  This 
could be explained by an initial switch event on the unex- 
pressed chromosome followed by switching on the expressed 
chromosome and subsequent  membrane IgG1  expression. 
Thus, early in culture, when cells have rearranged only one 
of their chromosomes, a substantial fraction of cells that will 
eventually switch will still be surface IgG1- but later, when 
such cells have rearranged both chromosomes, they will be 
transferred to the surface IgG1 + category. This assumes that 
the entry of new cells into the switching process has dimin- 
ished or ceased by day 4.5.  Indeed, if we assume that few 
cells enter the switching process after 3.5 d, then one could 
also explain the fall in percent S/z-S3,1 rearrangement among 
surface IgG1-  cells by assuming that some cells had been 
caught between the rearrangement event on the expressed 
chromosome and the membrane expression of IgG1 derived 
from that chromosome. 
It is interesting to note that the maximum frequency of 
cells that express membrane IgG1 in these experiments was 
"~,50%, consistent with a large body of experience in our 
laboratory of B cells stimulated with LPS and IL-4. The fact 
that IgG1- cells at days 4.5 and 5.5 have relatively low levels 
of S/z-S'y1 rearrangement implies that a substantial fraction 
of B cells cultured under these conditions do not undergo 
switch recombination. Indeed, even at days 4.5 and 5.5,  a 
major fraction of the B cells continue to express substantial 
amounts of slgM, implying that they have not switched to 
another isotype. These cells may be ones that would have 
"switched" had the culture been capable of sustaining switch 
events for a longer period. Alternatively, they may either have 
failed to receive a competent switch stimulus or, alternatively, 
may reflect cells that are incapable of switching in response 
to LPS plus IL-4. We cannot exclude the possibility that the 
initial B cell population is a heterogenous one that includes 
cells incapable of switching, at least to the set of stimuli that 
we have used. 
Our results do not eliminate the possibility that nondele- 
tional mechanisms of class switching do occur in a physio- 
logically meaningfifl manner. Since we do not measure switch 
recombination events in individual cells,  it is possible that 
the population of IgG1 + cells at 2.5 d, for example, includes 
some cells that have undergone S/Z-S3q deletional rearrange- 
ment on both chromosomes plus others that have not under- 
gone switch recombination, but are expressing IgG1 by one 
of the mechanisms mentioned above.  Furthermore, if mea- 
surement inaccuracy is not the explanation for the few cases 
where DNA deletion was insufficient to account for IgG1 
surface expression, then a small percentage of cells (up to 15%) 
may be producing IgG1 as a result of nonddetional mecha- 
nisms. Nonetheless it does appear that the weight of our evi- 
dence is consistent with deletional switching being the dom- 
inant mechanism even at the earliest time that expression of 
switched isotype can be observed. If nondeletional mecha- 
nisms are obligatory precursors to ddetional switch recom- 
bination, they must occur before membrane IgG1 expression 
and must have largely been replaced by ddetional mechanisms 
by the time surface IgG1 is expressed since under all condi- 
tions the majority of surface IgG1 + cells do express S/Z-S3~I 
rearrangement. 
Finally, it must be pointed out that stimulation of Ig class 
switching by other stimuli could,  conceivably, rdy more 
heavily on nondeletional mechanisms, although there is no 
a priori reason why this should be so. Efforts to examine in 
vivo switch events as well as switching in response to other 
stimuli are planned to address this issue. 
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